Latest filingSep 02, 2026Most recent Form 4
RVMD
Revolution Medicines, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$1.13B7 sells
Net open-market-$1.13B1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period7transactions
- S · Open-market sells · dominant7 · 100%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Director · dominant7 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeKim Lorence H.Common Stock · Indirect · Trust
72,790Aug 31, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- KH-$11.4M
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
RVMD transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 625 | -$12.8M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 2.12k | -$43.6M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 7.27k | -$148M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 26.1k | -$532M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 12.9k | -$261M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 6.59k | -$132M | S | — | 0.0% | 09/02 | 08/31 |
| RVMD | Kim Lorence H. | DIR | sale10b5-1 | 300 | -$6.01M | S | — | 0.0% | 09/02 | 08/31 |
Revolution Medicines, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Revolution Medicines, Inc.?
Kim Lorence H..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Kim Lorence H. reported a sale on Aug 31, 2026 valued at $12.8M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $11,381,287.60. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.